David R Brennan - Net Worth and Insider Trading
David R Brennan Net Worth
The estimated net worth of David R Brennan is at least $6 Million dollars as of 2024-11-13. David R Brennan is the Director of Insmed Inc and owns about 80,876 shares of Insmed Inc (INSM) stock worth over $6 Million. Details can be seen in David R Brennan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R Brennan has not made any transactions after 2021-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David R Brennan
David R Brennan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R Brennan owns 3 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Insmed Inc (INSM) , and Innocoll Holdings PLC (INNL) .
Click here to see the complete history of David R Brennan’s form 4 insider trades.
Insider Ownership Summary of David R Brennan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-05-14 | director |
| INSM | Insmed Inc | 2021-11-01 | director |
| INNL | Innocoll Holdings PLC | 2017-07-24 | director |
David R Brennan Latest Holdings Summary
David R Brennan currently owns a total of 1 stock. David R Brennan owns 80,876 shares of Insmed Inc (INSM) as of November 1, 2021, with a value of $6 Million.
Latest Holdings of David R Brennan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INSM | Insmed Inc | 2021-11-01 | 80,876 | 70.12 | 5,671,025 |
Holding Weightings of David R Brennan
David R Brennan Form 4 Trading Tracker
According to the SEC Form 4 filings, David R Brennan has made a total of 1 transactions in Insmed Inc (INSM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insmed Inc is the acquisition of 10,000 shares on November 1, 2021, which cost David R Brennan around $301,500.
Insider Trading History of David R Brennan
- 1
David R Brennan Trading Performance
GuruFocus tracks the stock performance after each of David R Brennan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R Brennan is -23.64%. GuruFocus also compares David R Brennan's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R Brennan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David R Brennan's insider trading performs compared to the benchmark.
Performance of David R Brennan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.04 | | | | | |
| Relative Return to S&P 500(%) | -11.86 | | | | | |
David R Brennan Ownership Network
Ownership Network List of David R Brennan
Ownership Network Relation of David R Brennan
David R Brennan Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
David R Brennan is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
David R Brennan Mailing Address
Above is the net worth, insider trading, and ownership report for David R Brennan. You might contact David R Brennan via mailing address: C/o Insmed Incorporated, 10 Finderne Avenue, Bridgewater Nj 08807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
